SHAREHOLDER ALERT: WeissLaw LLP Investigates MDC Partners Inc.

NEW YORK, July 9, 2021 /PRNewswire/ — URGENT: STOCKHOLDER VOTE SET FOR July 26, 2021 …

NEW YORK, July 9, 2021 /PRNewswire/ — URGENT: STOCKHOLDER VOTE SET FOR July 26, 2021

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MDC Partners Inc. («MDC» or the «Company») (NASDAQ: MDCA) in connection with the Company’s proposed stock-for -stock combination with Stagwell Media LP («Stagwell»).  The terms of the recently-amended merger agreement will result in current MDC shareholders retaining 31% of the equity of the combined company, with Stagwell receiving share consideration equal to 69% of the new entity.  Including Stagwell’s current ownership of MDC shares, Stagwell is still expected to gain control of approximately 74% of the post-transaction combined company. 

If you own MDC shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website: 

Or please contact:

Joshua Rubin, Esq.

WeissLaw LLP

1500 Broadway, 16th Floor

New York, NY  10036

(212) 682-3025

(888) 593-4771 

WeissLaw is investigating whether the special committee of MDC’s board («Special Committee») acted in the best interest of MDC’s public shareholders in agreeing to the proposed transaction, whether the Special Committee was fully informed as to the valuation of MDC and Stagwell, and whether all information regarding the process undertaken by the board and Special Committee and the valuation of the transaction will be fully and fairly disclosed to MDC’s public shareholders. 

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at 

Cision View original content to download multimedia: